as 12-27-2024 10:40am EST
Founded: | 1972 | Country: | United States |
Employees: | N/A | City: | LEHI |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | $19.50 | AVG Volume (30 days): | 43.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.88 | EPS Growth: | 114.95 |
52 Week Low/High: | $10.81 - $21.72 | Next Earning Date: | 11-07-2024 |
Revenue: | $445,095,000 | Revenue Growth: | 1.36% |
Revenue Growth (this year): | 2.07% | Revenue Growth (next year): | 2.62% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | NATR | 10% Owner | Oct 15 '24 | Sell | $13.02 | 2,300 | $29,946.00 | 64,167 |
NATR Breaking Stock News: Dive into NATR Ticker-Specific Updates for Smart Investing
StockStory
8 days ago
StockStory
9 days ago
Simply Wall St.
16 days ago
GlobeNewswire
24 days ago
StockStory
24 days ago
Simply Wall St.
a month ago
StockStory
a month ago
StockStory
a month ago
The information presented on this page, "NATR Nature's Sunshine Products Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.